- Home
- NVEI vs ASH Comparison
NVEI vs ASH Comparison
Compare NVEI & ASH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVEI
- ASH
- Stock Information
- Founded
- NVEI 2003
- ASH 1924
- Country
- NVEI Canada
- ASH United States
- Employees
- NVEI N/A
- ASH N/A
- Industry
- NVEI
- ASH Specialty Chemicals
- Sector
- NVEI
- ASH Consumer Discretionary
- Exchange
- NVEI Nasdaq
- ASH Nasdaq
- Market Cap
- NVEI 4.7B
- ASH 4.1B
- IPO Year
- NVEI 2021
- ASH N/A
- Fundamental
- Price
- NVEI $33.99
- ASH $76.74
- Analyst Decision
- NVEI Hold
- ASH Strong Buy
- Analyst Count
- NVEI 14
- ASH 8
- Target Price
- NVEI $32.38
- ASH $102.86
- AVG Volume (30 Days)
- NVEI 1.1M
- ASH 452.3K
- Earning Date
- NVEI 11-12-2024
- ASH 11-06-2024
- Dividend Yield
- NVEI 1.18%
- ASH 2.10%
- EPS Growth
- NVEI N/A
- ASH 1.05
- EPS
- NVEI 0.16
- ASH 3.35
- Revenue
- NVEI $1,359,722,000.00
- ASH $2,113,000,000.00
- Revenue This Year
- NVEI $18.83
- ASH $1.09
- Revenue Next Year
- NVEI $15.63
- ASH $4.54
- P/E Ratio
- NVEI $203.07
- ASH $19.48
- Revenue Growth
- NVEI 24.89
- ASH N/A
- 52 Week Low
- NVEI $19.07
- ASH $76.33
- 52 Week High
- NVEI $34.00
- ASH $102.50
- Technical
- Relative Strength Index (RSI)
- NVEI 72.51
- ASH 32.79
- Support Level
- NVEI $33.42
- ASH $77.00
- Resistance Level
- NVEI $33.70
- ASH $88.89
- Average True Range (ATR)
- NVEI 0.13
- ASH 1.86
- MACD
- NVEI 0.04
- ASH -0.77
- Stochastic Oscillator
- NVEI 98.49
- ASH 7.23
About NVEI Nuvei Corporation Subordinate Voting Shares
Nuvei Corp is a provider of payment technology solutions to merchants and partners. The solutions provided are mobile payments, online payments, and In-store payments. Its geographical segments are North America; Europe, the Middle East, and Africa; Latin America; and the Asia Pacific. The vast majority of the company's revenue is generated from North America and EMEA.
About ASH Ashland Inc.
Ashland Inc is a world-wide specialty materials company that serves a wide range of industrial markets. The company has a business-centric operating model and is organized into four distinct segments: life sciences, personal care, specialty additives, and intermediates. Key customers for the firm include pharmaceutical companies and manufacturers of personal care products, food and beverages, and nutraceuticals and supplements. The life sciences segment derives maximum revenue. Ashland includes only U.S. and Canada in its North America designation and includes Europe, the Middle East and Africa in its Europe designation.